Clinical Studies

VSL#3 is supported by Level One (double-blind, placebo-controlled) scientific data. It has a 15-year track record of demonstrated clinical benefits. Over 170 published studies and reviews have been released.

The following research material is made available for information purposes only.


  • Lee J., et al. Korean J Gastroenterol. Vol. 60n. 2:94-101 (2012)
  • Tursi A., et al. Am J Gastroenterol 105:2218-27 (2010)
  • Ng S.C., et al. Inflamm Bowel Dis. 16:1286-98 (2010)
  • Sood A., et al. Clin Gastroenterol Hepatol 11:1202-9 (2009)
  • Hien H.Q., et al. Inflamm Bowel Dis 15: 760-768 (2009)
  • Miele E., et al. Am J Gastroenterology 104:437-443 (2009)
  • Tursi A., et al. Int J Colorectal Dis 22:1103-8 (2007)
  • Karimi O., et al. Drugs Today 41:453-9 (2005)
  • Tursi A., et al. Med Sci Monit 10:PI126-131 (2004)
  • Venturi A., et al. Aliment Pharmacol Ther 13:1103-1108 (1999)
  • Friederich P., et al. Int J Colorectal Dis. 26:575-82 (2011)
  • Pronio A., et al. Inflamm Bowel Dis 14:662-668 (2008)
  • Gionchetti P., et al. Dis Colon Rectum 50(12):2075-84 (2007)
  • Kuehbacher T., et al. Gut 55:833-841 (2006)
  • Mimura T., et al. Gut 53:108-114 (2004)
  • Gionchetti P., et al. Gastroenterology 124:1202-09 (2003)
  • Ulisse S., et al. Am J Gastroenterology 96:2691- 2699 (2001)
  • Gionchetti P., et al. Gastroenterology 119:305-309 (2000)
  • Turroni S., et al. World J Gastroenterol 16: 30-41 (2010)

For Canadian Healthcare Professionals

To request additional medical/scientific information on VSL#3, please contact our Medical Information Centre: